Work

Tumor lysate-cloaked CuMOF-sorafenib nanoassembler: A synergistic cuproptosis-ferroptosis nanoweapon against tumors

Year: 2025
Type: article
Abstract: studies demonstrate the efficient tumor accumulation, growth suppression, and metastasis inhibition of CMSP. By integrating biomimetic targeting, oxidative stress amplification, and dual-pathway synergy, CMSP presents a promising strategy to advance the development of personalized antitumor nanomedicines.
Language: English
Open Access status: gold
Estimated APC paid: $3,400
OpenAlex ID: W4417048536
FWCI: 0.241
Cites: 57
Cited by: 1
Related to: